Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users

American Journal of Drug and Alcohol Abuse

Volumn 39, Issue 3, 2013, Pages 211-216

  Babson, Kimberly A ^a,b   Boden, Matthew Tyler ^a   Bonn Miller, Marcel O ^c,d  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CENTER FOR HEALTH CARE EVALUATION   (United States)

Author keywords

Cannabis; Depression; Medical marijuana; Sleep

Indexed keywords

ALCOHOL; CANNABIS; COCAINE;

ADULT; ARTICLE; CANNABIS ADDICTION; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PHYSICIAN; PITTSBURGH SLEEP QUALITY INDEX; PRESCRIPTION; SLEEP QUALITY;

ADULT; CANNABIS; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; REGRESSION ANALYSIS; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84878432865     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2013.788183     Document Type: Article

References (36)

1. Ogborne A, Smart R, Adlaf E. Self-reported medical use of marijuana: A survey of the general population. CMAJ 2000; 162:1685-1686.
2. Ogborne A, Smart R, Weber T, Birchmore-Timney C. Who is using cannabis as a medicine and why: An exploratory study. J Psychoactive Drugs 2000; 32:435-443.
3. Nunberg H, Kilmer B, Pacula R, Burgdorf J. An analysis of applicants presenting to a medical marijuana specialty practice in California. J Drug Policy Analysis 2011; 4:1-18.
4. Bonn-Miller M, Boden M, Bucossi M, Babson K. Cannabis use characteristics, patterns, and helpfulness among medical can-nabis users. Submitted, 2012.
5. Merikangas K, Mehta R, Molnar B, Walters E, Swendsen J, Aguilar-Gaziola S, Bijl R, Borges G, Caraveo-Andvaga J, Dewit D, Kolody B, Vega W, Wittchen H, Kessler R. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the international consortium in psychiatric epidemiology. Addict Behav 1989; 23:893-907.
6. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addict 2003; 98:1493-1504.
7. Milich R, Lynam D, Zimmerman R, Logan T, Martin C, Leukefeld C, Partis C, Miller J, Clayton R. Differences in young adult psychopathology among drug abstainers, experimenters, and frequent users. J Subst Abuse 2000; 11:69-88.
8. Troisi A, Pasini A, Saracco M, Spalletta G. Psychiatric symptoms in male cannabis users not using other illicit drugs. Addict 1998; 93:487-492.
9. Rowe M, Fleming M, Barry K, Manwell L, Kropp S. Correlates of depression in primary care. J Fam Pract 1995; 41:551-558.
10. Grant B. Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. J Subst Abuse 1995; 7:481-497.
11. Ford D, Kamerow D. Epidemiologic study of sleep disturbances and psychiatric disorders. J Am Med Assoc 1989; 262:1479-1484.
12. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev 2010; 14:35-46.
13. Stewart R, Besset A, Bebbington P, Brugha T, Lindesay J, Jenkins R, Singleton N, Meltzer H. Insomnia comorbidity and impact and hypnotic use by age group in a national survey population aged 16 to 74 years. Sleep 2006; 29:1391-1397.
14. Taylor D, Lichstein K, Durrence H. Insomnia as a health risk factor. Behav Sleep Med 2003; 1:227-247.
15. Wong M, Brower K, Fitzgerald H, Zucker R. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescents. Alcohol Clin Exp Res 2004; 28:578-587.
16. Bonn-Miller M, Babson K, Vujanovic A, Feldner M. Sleep problems and PTSD symptoms interact to predict marijuana use coping motives. J Dual Diagnosis 2010; 6:111-122.
17. Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy, and marijuana. Sleep Med Rev 2008; 12:381-389.
18. Grant B, Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: Results from the national longitudinal alcohol epidemiologic survey. J Subst Abuse 1998; 10:255-264.
19. Bonn-Miller M, Zvolensky M. An evaluation of the nature of marijuana use and its motives among young adult active users. Am J Addict 2009; 18:409-416.
20. Bovasso G. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001; 158:2033-2037.
21. Marmorstein N, Iacono W. Explaining associations between cannabis use disorders in adolescence and later major depression: A test of the psychosocial failure model. Addict Behav 2011; 36:773-776.
22. Fairman B, Anthony J. Are early-onset cannabis smokers at an increased risk for depression spells? J Affect Disord 2012; 138:54-62.
23. Cole J, Motivala S, Buysse D, Oxman M, Levin M, Irwin M. Validation of a 3-factor scoring model for the Pittsburgh Sleep Quality Index in Older Adults. Sleep 2006; 29:112-116.
24. Nicholson A, Turner C, Stone B, Philip R. Effect of Delta-9- tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 2004; 24:305-313.
25. Watson D, O'Hara M, Simms L, Kotov R, Chmielewski M, McDade-Montez E, Gamez W, Stuart S. Development and validation of the inventory of depression and anxiety symptoms (IDAS). Psychol Assess 2007; 19:253-268.
26. Watson D, Chmielewski M, McDade-Montez E, Koffel E, Naragon K, Stuart S. Further validation of the IDAS: Evidence of convergent, discriminant, criterion, and incremental validity. Psychol Assess 2008; 20:248-259.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed.), Text revision. Washington, DC: American Psychiatric Association, 2000.
28. Buysse D, Reynolds C, Monk T, Berman S. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28:193-213.
29. Adamson S, Kay-Lambkin F, Baker A, Lewin T, Thornton L, Kelly B, Sellman J. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R). Drug Alcohol Depend 2000; 110:137-143.
30. Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption II. Addict 1993; 88:791-804.
31. Hubbard R, Marsden M, Rachal J, Harwood H, Cavanaugh E, Ginzburg H. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press, 1989.
32. Bonn-Miller M, Moos R. Marijuana discontinuation, anxiety symptoms, and relapse to marijuana. Addict Behav 2009; 34:782-785.
33. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (2nd ed.). Hillsdale, NJ: L. Erlbaum Associates, 1983.
34. Simmons J, Nelson L, Simonsohn U. False-positive psychology: Undisclosed flexibility in data collection and analysis allows presenting anything as significant. Psychol Sci 2011; 22:1359-1366.
35. Cohen J, Cohen P, West S, Aiken L. Applied Multiple Regression/ Correlation Analysis for the Behavioral Sciences (3rd ed.). Mahwah, NJ: Erlbaum, 2003.
36. Aiken L, West S, ed. Multiple Regression: Testing and Interpreting Interactions. Newbury Park, CA: Sage, 1991.